Industry Research Reports
Home > Reports > Service & Software > Global Ophthalmology AI Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Ophthalmology AI Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-07-31
Pages: 154 Pages
Report ld: 4816233
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Ophthalmology AI Screening Software Market Size(US$)
CAGR 2025-2031
28.2%
Market Size,2031
USD 9,023
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,032 million
Market Forecast in 2031(Value)
US$ 9,023 million
CAGR
28.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Ophthalmology AI Screening Software market is projected to grow from US$ 1621 million in 2024 to US$ 9023 million by 2031, at a CAGR of 28.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Ophthalmic AI screening software is an artificial intelligence software used in the field of ophthalmic disease screening. It is based on deep learning algorithms and realizes automatic screening, auxiliary diagnosis and condition assessment of ophthalmic diseases by analyzing ophthalmic related data such as fundus images.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Ophthalmology AI Screening Software leading manufacturers including Eyenuk, Inc., DeepMind, Remidio, Retmarker, AEYE Health, RetinaLyze, Synapxe, Intelligent Retinal Imaging Systems, RetinAI, RetinaRisk, etc., dominate supply; the top five capture approximately % of global revenue, with Eyenuk, Inc. leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Ophthalmology AI Screening Software market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Eyenuk, Inc.
- DeepMind
- Remidio
- Retmarker
- AEYE Health
- RetinaLyze
- Synapxe
- Intelligent Retinal Imaging Systems
- RetinAI
- RetinaRisk
- CSIRO
- Airdoc
- Silicon Intelligence
- Zhiyuan Huitu
- WeDoctor Group
- VoxelCloud
- Kangfuzi Health
- Zhenhealth
- Tencent Health
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- On-premises
- Cloud-based
Segment by Application
- Hospital
- Eye Clinic
- Medical Research
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Ophthalmology AI Screening Software study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Ophthalmology AI Screening Software: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Ophthalmology AI Screening Software Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 On-premises
1.2.3 Cloud-based
1.3 Market Segmentation by Application
1.3.1 Global Ophthalmology AI Screening Software Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Eye Clinic
1.3.4 Medical Research
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Ophthalmology AI Screening Software Revenue Estimates and Forecasts 2020-2031
2.2 Global Ophthalmology AI Screening Software Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Ophthalmology AI Screening Software Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Ophthalmology AI Screening Software Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 On-premises Market Size by Players
3.3.2 Cloud-based Market Size by Players
3.4 Global Ophthalmology AI Screening Software Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Ophthalmology AI Screening Software Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Ophthalmology AI Screening Software Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Ophthalmology AI Screening Software Market Size by Type (2020-2031)
6.4 North America Ophthalmology AI Screening Software Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Ophthalmology AI Screening Software Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Ophthalmology AI Screening Software Market Size by Type (2020-2031)
7.4 Europe Ophthalmology AI Screening Software Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Ophthalmology AI Screening Software Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Ophthalmology AI Screening Software Market Size by Type (2020-2031)
8.4 Asia-Pacific Ophthalmology AI Screening Software Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Ophthalmology AI Screening Software Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Ophthalmology AI Screening Software Market Size by Type (2020-2031)
9.4 Central and South America Ophthalmology AI Screening Software Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Ophthalmology AI Screening Software Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Ophthalmology AI Screening Software Market Size by Type (2020-2031)
10.4 Middle East and Africa Ophthalmology AI Screening Software Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Ophthalmology AI Screening Software Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Eyenuk, Inc.
11.1.1 Eyenuk, Inc. Corporation Information
11.1.2 Eyenuk, Inc. Business Overview
11.1.3 Eyenuk, Inc. Ophthalmology AI Screening Software Product Features and Attributes
11.1.4 Eyenuk, Inc. Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.1.5 Eyenuk, Inc. Ophthalmology AI Screening Software Revenue by Product in 2024
11.1.6 Eyenuk, Inc. Ophthalmology AI Screening Software Revenue by Application in 2024
11.1.7 Eyenuk, Inc. Ophthalmology AI Screening Software Revenue by Geographic Area in 2024
11.1.8 Eyenuk, Inc. Ophthalmology AI Screening Software SWOT Analysis
11.1.9 Eyenuk, Inc. Recent Developments
11.2 DeepMind
11.2.1 DeepMind Corporation Information
11.2.2 DeepMind Business Overview
11.2.3 DeepMind Ophthalmology AI Screening Software Product Features and Attributes
11.2.4 DeepMind Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.2.5 DeepMind Ophthalmology AI Screening Software Revenue by Product in 2024
11.2.6 DeepMind Ophthalmology AI Screening Software Revenue by Application in 2024
11.2.7 DeepMind Ophthalmology AI Screening Software Revenue by Geographic Area in 2024
11.2.8 DeepMind Ophthalmology AI Screening Software SWOT Analysis
11.2.9 DeepMind Recent Developments
11.3 Remidio
11.3.1 Remidio Corporation Information
11.3.2 Remidio Business Overview
11.3.3 Remidio Ophthalmology AI Screening Software Product Features and Attributes
11.3.4 Remidio Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.3.5 Remidio Ophthalmology AI Screening Software Revenue by Product in 2024
11.3.6 Remidio Ophthalmology AI Screening Software Revenue by Application in 2024
11.3.7 Remidio Ophthalmology AI Screening Software Revenue by Geographic Area in 2024
11.3.8 Remidio Ophthalmology AI Screening Software SWOT Analysis
11.3.9 Remidio Recent Developments
11.4 Retmarker
11.4.1 Retmarker Corporation Information
11.4.2 Retmarker Business Overview
11.4.3 Retmarker Ophthalmology AI Screening Software Product Features and Attributes
11.4.4 Retmarker Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.4.5 Retmarker Ophthalmology AI Screening Software Revenue by Product in 2024
11.4.6 Retmarker Ophthalmology AI Screening Software Revenue by Application in 2024
11.4.7 Retmarker Ophthalmology AI Screening Software Revenue by Geographic Area in 2024
11.4.8 Retmarker Ophthalmology AI Screening Software SWOT Analysis
11.4.9 Retmarker Recent Developments
11.5 AEYE Health
11.5.1 AEYE Health Corporation Information
11.5.2 AEYE Health Business Overview
11.5.3 AEYE Health Ophthalmology AI Screening Software Product Features and Attributes
11.5.4 AEYE Health Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.5.5 AEYE Health Ophthalmology AI Screening Software Revenue by Product in 2024
11.5.6 AEYE Health Ophthalmology AI Screening Software Revenue by Application in 2024
11.5.7 AEYE Health Ophthalmology AI Screening Software Revenue by Geographic Area in 2024
11.5.8 AEYE Health Ophthalmology AI Screening Software SWOT Analysis
11.5.9 AEYE Health Recent Developments
11.6 RetinaLyze
11.6.1 RetinaLyze Corporation Information
11.6.2 RetinaLyze Business Overview
11.6.3 RetinaLyze Ophthalmology AI Screening Software Product Features and Attributes
11.6.4 RetinaLyze Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.6.5 RetinaLyze Recent Developments
11.7 Synapxe
11.7.1 Synapxe Corporation Information
11.7.2 Synapxe Business Overview
11.7.3 Synapxe Ophthalmology AI Screening Software Product Features and Attributes
11.7.4 Synapxe Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.7.5 Synapxe Recent Developments
11.8 Intelligent Retinal Imaging Systems
11.8.1 Intelligent Retinal Imaging Systems Corporation Information
11.8.2 Intelligent Retinal Imaging Systems Business Overview
11.8.3 Intelligent Retinal Imaging Systems Ophthalmology AI Screening Software Product Features and Attributes
11.8.4 Intelligent Retinal Imaging Systems Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.8.5 Intelligent Retinal Imaging Systems Recent Developments
11.9 RetinAI
11.9.1 RetinAI Corporation Information
11.9.2 RetinAI Business Overview
11.9.3 RetinAI Ophthalmology AI Screening Software Product Features and Attributes
11.9.4 RetinAI Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.9.5 RetinAI Recent Developments
11.10 RetinaRisk
11.10.1 RetinaRisk Corporation Information
11.10.2 RetinaRisk Business Overview
11.10.3 RetinaRisk Ophthalmology AI Screening Software Product Features and Attributes
11.10.4 RetinaRisk Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 CSIRO
11.11.1 CSIRO Corporation Information
11.11.2 CSIRO Business Overview
11.11.3 CSIRO Ophthalmology AI Screening Software Product Features and Attributes
11.11.4 CSIRO Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.11.5 CSIRO Recent Developments
11.12 Airdoc
11.12.1 Airdoc Corporation Information
11.12.2 Airdoc Business Overview
11.12.3 Airdoc Ophthalmology AI Screening Software Product Features and Attributes
11.12.4 Airdoc Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.12.5 Airdoc Recent Developments
11.13 Silicon Intelligence
11.13.1 Silicon Intelligence Corporation Information
11.13.2 Silicon Intelligence Business Overview
11.13.3 Silicon Intelligence Ophthalmology AI Screening Software Product Features and Attributes
11.13.4 Silicon Intelligence Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.13.5 Silicon Intelligence Recent Developments
11.14 Zhiyuan Huitu
11.14.1 Zhiyuan Huitu Corporation Information
11.14.2 Zhiyuan Huitu Business Overview
11.14.3 Zhiyuan Huitu Ophthalmology AI Screening Software Product Features and Attributes
11.14.4 Zhiyuan Huitu Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.14.5 Zhiyuan Huitu Recent Developments
11.15 WeDoctor Group
11.15.1 WeDoctor Group Corporation Information
11.15.2 WeDoctor Group Business Overview
11.15.3 WeDoctor Group Ophthalmology AI Screening Software Product Features and Attributes
11.15.4 WeDoctor Group Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.15.5 WeDoctor Group Recent Developments
11.16 VoxelCloud
11.16.1 VoxelCloud Corporation Information
11.16.2 VoxelCloud Business Overview
11.16.3 VoxelCloud Ophthalmology AI Screening Software Product Features and Attributes
11.16.4 VoxelCloud Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.16.5 VoxelCloud Recent Developments
11.17 Kangfuzi Health
11.17.1 Kangfuzi Health Corporation Information
11.17.2 Kangfuzi Health Business Overview
11.17.3 Kangfuzi Health Ophthalmology AI Screening Software Product Features and Attributes
11.17.4 Kangfuzi Health Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.17.5 Kangfuzi Health Recent Developments
11.18 Zhenhealth
11.18.1 Zhenhealth Corporation Information
11.18.2 Zhenhealth Business Overview
11.18.3 Zhenhealth Ophthalmology AI Screening Software Product Features and Attributes
11.18.4 Zhenhealth Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.18.5 Zhenhealth Recent Developments
11.19 Tencent Health
11.19.1 Tencent Health Corporation Information
11.19.2 Tencent Health Business Overview
11.19.3 Tencent Health Ophthalmology AI Screening Software Product Features and Attributes
11.19.4 Tencent Health Ophthalmology AI Screening Software Revenue and Gross Margin (2020-2025)
11.19.5 Tencent Health Recent Developments
12 Ophthalmology AI Screening SoftwareIndustry Chain Analysis
12.1 Ophthalmology AI Screening Software Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Ophthalmology AI Screening Software Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Ophthalmology AI Screening Software Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Ophthalmology AI Screening Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Ophthalmology AI Screening Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Ophthalmology AI Screening Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Ophthalmology AI Screening Software Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Ophthalmology AI Screening Software Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Ophthalmology AI Screening Software Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Ophthalmology AI Screening Software Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Ophthalmology AI Screening Software by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmology AI Screening Software as of 2024)
Table 11. Global Ophthalmology AI Screening Software Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Ophthalmology AI Screening Software Companies Headquarters
Table 13. Global Ophthalmology AI Screening Software Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Ophthalmology AI Screening Software Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Ophthalmology AI Screening Software Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Ophthalmology AI Screening Software Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Ophthalmology AI Screening Software Revenue by Application (2026-2031) & (US$ Million)
Table 21. Ophthalmology AI Screening Software High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Ophthalmology AI Screening Software Growth Accelerators and Market Barriers
Table 25. North America Ophthalmology AI Screening Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Ophthalmology AI Screening Software Growth Accelerators and Market Barriers
Table 27. Europe Ophthalmology AI Screening Software Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Ophthalmology AI Screening Software Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Ophthalmology AI Screening Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Ophthalmology AI Screening Software Investment Opportunities and Key Challenges
Table 31. Central and South America Ophthalmology AI Screening Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Ophthalmology AI Screening Software Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Ophthalmology AI Screening Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Eyenuk, Inc. Corporation Information
Table 35. Eyenuk, Inc. Description and Major Businesses
Table 36. Eyenuk, Inc. Product Features and Attributes
Table 37. Eyenuk, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Eyenuk, Inc. Revenue Proportion by Product in 2024
Table 39. Eyenuk, Inc. Revenue Proportion by Application in 2024
Table 40. Eyenuk, Inc. Revenue Proportion by Geographic Area in 2024
Table 41. Eyenuk, Inc. Ophthalmology AI Screening Software SWOT Analysis
Table 42. Eyenuk, Inc. Recent Developments
Table 43. DeepMind Corporation Information
Table 44. DeepMind Description and Major Businesses
Table 45. DeepMind Product Features and Attributes
Table 46. DeepMind Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. DeepMind Revenue Proportion by Product in 2024
Table 48. DeepMind Revenue Proportion by Application in 2024
Table 49. DeepMind Revenue Proportion by Geographic Area in 2024
Table 50. DeepMind Ophthalmology AI Screening Software SWOT Analysis
Table 51. DeepMind Recent Developments
Table 52. Remidio Corporation Information
Table 53. Remidio Description and Major Businesses
Table 54. Remidio Product Features and Attributes
Table 55. Remidio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Remidio Revenue Proportion by Product in 2024
Table 57. Remidio Revenue Proportion by Application in 2024
Table 58. Remidio Revenue Proportion by Geographic Area in 2024
Table 59. Remidio Ophthalmology AI Screening Software SWOT Analysis
Table 60. Remidio Recent Developments
Table 61. Retmarker Corporation Information
Table 62. Retmarker Description and Major Businesses
Table 63. Retmarker Product Features and Attributes
Table 64. Retmarker Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Retmarker Revenue Proportion by Product in 2024
Table 66. Retmarker Revenue Proportion by Application in 2024
Table 67. Retmarker Revenue Proportion by Geographic Area in 2024
Table 68. Retmarker Ophthalmology AI Screening Software SWOT Analysis
Table 69. Retmarker Recent Developments
Table 70. AEYE Health Corporation Information
Table 71. AEYE Health Description and Major Businesses
Table 72. AEYE Health Product Features and Attributes
Table 73. AEYE Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. AEYE Health Revenue Proportion by Product in 2024
Table 75. AEYE Health Revenue Proportion by Application in 2024
Table 76. AEYE Health Revenue Proportion by Geographic Area in 2024
Table 77. AEYE Health Ophthalmology AI Screening Software SWOT Analysis
Table 78. AEYE Health Recent Developments
Table 79. RetinaLyze Corporation Information
Table 80. RetinaLyze Description and Major Businesses
Table 81. RetinaLyze Product Features and Attributes
Table 82. RetinaLyze Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. RetinaLyze Recent Developments
Table 84. Synapxe Corporation Information
Table 85. Synapxe Description and Major Businesses
Table 86. Synapxe Product Features and Attributes
Table 87. Synapxe Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Synapxe Recent Developments
Table 89. Intelligent Retinal Imaging Systems Corporation Information
Table 90. Intelligent Retinal Imaging Systems Description and Major Businesses
Table 91. Intelligent Retinal Imaging Systems Product Features and Attributes
Table 92. Intelligent Retinal Imaging Systems Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Intelligent Retinal Imaging Systems Recent Developments
Table 94. RetinAI Corporation Information
Table 95. RetinAI Description and Major Businesses
Table 96. RetinAI Product Features and Attributes
Table 97. RetinAI Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. RetinAI Recent Developments
Table 99. RetinaRisk Corporation Information
Table 100. RetinaRisk Description and Major Businesses
Table 101. RetinaRisk Product Features and Attributes
Table 102. RetinaRisk Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. RetinaRisk Recent Developments
Table 104. CSIRO Corporation Information
Table 105. CSIRO Description and Major Businesses
Table 106. CSIRO Product Features and Attributes
Table 107. CSIRO Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. CSIRO Recent Developments
Table 109. Airdoc Corporation Information
Table 110. Airdoc Description and Major Businesses
Table 111. Airdoc Product Features and Attributes
Table 112. Airdoc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Airdoc Recent Developments
Table 114. Silicon Intelligence Corporation Information
Table 115. Silicon Intelligence Description and Major Businesses
Table 116. Silicon Intelligence Product Features and Attributes
Table 117. Silicon Intelligence Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Silicon Intelligence Recent Developments
Table 119. Zhiyuan Huitu Corporation Information
Table 120. Zhiyuan Huitu Description and Major Businesses
Table 121. Zhiyuan Huitu Product Features and Attributes
Table 122. Zhiyuan Huitu Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Zhiyuan Huitu Recent Developments
Table 124. WeDoctor Group Corporation Information
Table 125. WeDoctor Group Description and Major Businesses
Table 126. WeDoctor Group Product Features and Attributes
Table 127. WeDoctor Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. WeDoctor Group Recent Developments
Table 129. VoxelCloud Corporation Information
Table 130. VoxelCloud Description and Major Businesses
Table 131. VoxelCloud Product Features and Attributes
Table 132. VoxelCloud Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. VoxelCloud Recent Developments
Table 134. Kangfuzi Health Corporation Information
Table 135. Kangfuzi Health Description and Major Businesses
Table 136. Kangfuzi Health Product Features and Attributes
Table 137. Kangfuzi Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Kangfuzi Health Recent Developments
Table 139. Zhenhealth Corporation Information
Table 140. Zhenhealth Description and Major Businesses
Table 141. Zhenhealth Product Features and Attributes
Table 142. Zhenhealth Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Zhenhealth Recent Developments
Table 144. Tencent Health Corporation Information
Table 145. Tencent Health Description and Major Businesses
Table 146. Tencent Health Product Features and Attributes
Table 147. Tencent Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. Tencent Health Recent Developments
Table 149. Raw Materials Key Suppliers
Table 150. Distributors List
Table 151. Market Trends and Market Evolution
Table 152. Market Drivers and Opportunities
Table 153. Market Challenges, Risks, and Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Ophthalmology AI Screening Software Product Picture
Figure 2. Global Ophthalmology AI Screening Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. On-premises Product Picture
Figure 4. Cloud-based Product Picture
Figure 5. Global Ophthalmology AI Screening Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Eye Clinic
Figure 8. Medical Research
Figure 9. Others
Figure 10. Ophthalmology AI Screening Software Report Years Considered
Figure 11. Global Ophthalmology AI Screening Software Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 13. Global Ophthalmology AI Screening Software Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Ophthalmology AI Screening Software Revenue Market Share by Region (2020-2031)
Figure 15. Global Ophthalmology AI Screening Software Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. On-premises Revenue Market Share by Player in 2024
Figure 18. Cloud-based Revenue Market Share by Player in 2024
Figure 19. Global Ophthalmology AI Screening Software Revenue Market Share by Type (2020-2031)
Figure 20. Global Ophthalmology AI Screening Software Revenue Market Share by Application (2020-2031)
Figure 21. North America Ophthalmology AI Screening Software Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players Ophthalmology AI Screening Software Revenue (US$ Million) in 2024
Figure 23. North America Ophthalmology AI Screening Software Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America Ophthalmology AI Screening Software Revenue (US$ Million) by Application (2020-2031)
Figure 25. US Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 26. Canada Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 28. Europe Ophthalmology AI Screening Software Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players Ophthalmology AI Screening Software Revenue (US$ Million) in 2024
Figure 30. Europe Ophthalmology AI Screening Software Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe Ophthalmology AI Screening Software Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 33. France Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 35. Italy Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 36. Russia Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Ophthalmology AI Screening Software Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players Ophthalmology AI Screening Software Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific Ophthalmology AI Screening Software Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific Ophthalmology AI Screening Software Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 42. Japan Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 44. Australia Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 45. India Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore Ophthalmology AI Screening Software Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America Ophthalmology AI Screening Software Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players Ophthalmology AI Screening Software Revenue (US$ Million) in 2024
Figure 53. Central and South America Ophthalmology AI Screening Software Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America Ophthalmology AI Screening Software Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil Ophthalmology AI Screening Software Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina Ophthalmology AI Screening Software Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa Ophthalmology AI Screening Software Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players Ophthalmology AI Screening Software Revenue (US$ Million) in 2024
Figure 59. South America Ophthalmology AI Screening Software Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa Ophthalmology AI Screening Software Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries Ophthalmology AI Screening Software Revenue (2020-2025) & (US$ Million)
Figure 62. Israel Ophthalmology AI Screening Software Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt Ophthalmology AI Screening Software Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa Ophthalmology AI Screening Software Revenue (2020-2025) & (US$ Million)
Figure 65. Ophthalmology AI Screening Software Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Ophthalmology AI Screening Software in 2025?
The global market size of Ophthalmology AI Screening Software in 2025 was 2032 Million USD.
What was the global market size of Ophthalmology AI Screening Software in 2031?
Which region is expected to have the highest market share?
Which companies rank high in the global Ophthalmology AI Screening Software market?
What is the annual compound growth rate of the global Ophthalmology AI Screening Software market size from 2025 to 2031?
Related Reports
Global Ophthalmology AI Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Ophthalmology AI Screening Software market is projected to grow from US$ 2032 million in 2025 to US$ 11313 million by 2032, at a CAGR of 28.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-24
Pages: 155
USD 4900.00
(Single User License)
Global Ophthalmology AI Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Ophthalmology AI Screening Software market size was US$ 2032 million in 2025 and is forecast to reach a readjusted size of US$ 11313 million by 2032 with a CAGR of 28.2% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 110
USD 4250.00
(Single User License)
Ophthalmology AI Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Ophthalmology AI Screening Software was estimated to be worth US$ 2032 million in 2025 and is projected to reach US$ 11313 million, growing at a CAGR of 28.2% from 2026 to 2032.
Published Date: 2026-01-31
Pages: 128
USD 3950.00
(Single User License)
Global Ophthalmology AI Screening Software Market Research Report 2026
The global Ophthalmology AI Screening Software market was valued at US$ 2032 million in 2025 and is anticipated to reach US$ 11313 million by 2032, at a CAGR of 28.2% from 2026 to 2032.
Published Date: 2026-01-31
Pages: 131
USD 2900.00
(Single User License)
Global Ophthalmology AI Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Ophthalmology AI Screening Software market size was US$ 1621 million in 2024 and is forecast to a readjusted size of US$ 9023 million by 2031 with a CAGR of 28.2% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 109
USD 4250.00
(Single User License)
Ophthalmology AI Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ophthalmology AI Screening Software was estimated to be worth US$ 1621 million in 2024 and is forecast to a readjusted size of US$ 9023 million by 2031 with a CAGR of 28.2% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 129
USD 3950.00
(Single User License)
Global Ophthalmology AI Screening Software Market Research Report 2025
The global market for Ophthalmology AI Screening Software was valued at US$ 1621 million in the year 2024 and is projected to reach a revised size of US$ 9023 million by 2031, growing at a CAGR of 28.2% during the forecast period.
Published Date: 2025-03-12
Pages: 94
USD 2900.00
(Single User License)
Ophthalmology AI Screening Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ophthalmology AI Screening Software was estimated to be worth US$ 1621 million in 2024 and is forecast to a readjusted size of US$ 9023 million by 2031 with a CAGR of 28.2% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 135
USD 3950.00
(Single User License)
Global Ophthalmology AI Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Ophthalmology AI Screening Software market is projected to grow from US$ 2032 million in 2025 to US$ 11313 million by 2032, at a CAGR of 28.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-24
Pages: 155
USD 4900.00 (Single User License)Global Ophthalmology AI Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Ophthalmology AI Screening Software market size was US$ 2032 million in 2025 and is forecast to reach a readjusted size of US$ 11313 million by 2032 with a CAGR of 28.2% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 110
USD 4250.00 (Single User License)Ophthalmology AI Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Ophthalmology AI Screening Software was estimated to be worth US$ 2032 million in 2025 and is projected to reach US$ 11313 million, growing at a CAGR of 28.2% from 2026 to 2032.
Published: 2026-01-31
Pages: 128
USD 3950.00 (Single User License)Global Ophthalmology AI Screening Software Market Research Report 2026
The global Ophthalmology AI Screening Software market was valued at US$ 2032 million in 2025 and is anticipated to reach US$ 11313 million by 2032, at a CAGR of 28.2% from 2026 to 2032.
Published: 2026-01-31
Pages: 131
USD 2900.00 (Single User License)Global Ophthalmology AI Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Ophthalmology AI Screening Software market size was US$ 1621 million in 2024 and is forecast to a readjusted size of US$ 9023 million by 2031 with a CAGR of 28.2% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 109
USD 4250.00 (Single User License)Ophthalmology AI Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ophthalmology AI Screening Software was estimated to be worth US$ 1621 million in 2024 and is forecast to a readjusted size of US$ 9023 million by 2031 with a CAGR of 28.2% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 129
USD 3950.00 (Single User License)Global Ophthalmology AI Screening Software Market Research Report 2025
The global market for Ophthalmology AI Screening Software was valued at US$ 1621 million in the year 2024 and is projected to reach a revised size of US$ 9023 million by 2031, growing at a CAGR of 28.2% during the forecast period.
Published: 2025-03-12
Pages: 94
USD 2900.00 (Single User License)Ophthalmology AI Screening Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ophthalmology AI Screening Software was estimated to be worth US$ 1621 million in 2024 and is forecast to a readjusted size of US$ 9023 million by 2031 with a CAGR of 28.2% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 135
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now